Annapolis Financial Services’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-150
Closed -$1.09K 485
2023
Q3
$1.09K Hold
150
﹤0.01% 451
2023
Q2
$1.11K Hold
150
﹤0.01% 456
2023
Q1
$1.04K Hold
150
﹤0.01% 422
2022
Q4
$1.54K Hold
150
﹤0.01% 400
2022
Q3
$3K Hold
150
﹤0.01% 435
2022
Q2
$8K Hold
150
﹤0.01% 307
2022
Q1
$11K Hold
150
﹤0.01% 295
2021
Q4
$21K Hold
150
0.01% 258
2021
Q3
$31K Hold
150
0.01% 206
2021
Q2
$32K Buy
+150
New +$27.5K 0.01% 190

Other funds holding NVAX

Annapolis Financial Services's NVAX Position: Q4 2023 in Review

Annapolis Financial Services sold out of Novavax (NVAX) in Q4 2023, closing a stake of 150 shares — an estimated $1.09K sold.

Annapolis Financial Services first reported a position in NVAX in Q2 2021 and held it in 10 quarters. The position peaked at $32K in Q2 2021. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

  • Annapolis Financial Services reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
  • Annapolis Financial Services sold 150 Novavax shares in Q4 2023, an estimated $1.09K.
  • Annapolis Financial Services first reported a position in Novavax in Q2 2021 and held it in 10 quarters.
  • Annapolis Financial Services's Novavax position peaked at $32K in Q2 2021.
  • 199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on Annapolis Financial Services's 13F filing for Q4 2023, filed 1 Feb 2024.